2096 fundamentals
SIMCERE PHARMACEUTICAL GRP LTD revenue breakdown overview
SIMCERE PHARMACEUTICAL GRP LTD revenue for the last year amounted to 7.27 B HKD, the most of which — 7.30 B HKD — came from its highest performing source at the moment, Pharmaceutical Products. The greatest contribution to the revenue figure was made by China — last year it brought SIMCERE PHARMACEUTICAL GRP LTD 7.30 B HKD, and the year before that — 7.35 B HKD.
By source
2017
2018
2019
2020
2021
2022
2023
0.00
2.00 B
4.00 B
6.00 B
8.00 B
Pharmaceutical Products
Nervous System
Oncology
Autoimmune
Other
Promotion Service
Anti-infective Products
Cardiovascular Products
Currency: HKD
2017
2018
2019
2020
2021
2022
2023
Pharmaceutical Products
—
—
—
—
7.30 B
Nervous System
1.06 B
791.08 M
1.86 B
2.64 B
—
Oncology
1.78 B
1.41 B
1.45 B
1.66 B
—
Autoimmune
922.77 M
1.26 B
1.08 B
1.49 B
—
Other
453.14 M
1.29 B
1.15 B
1.56 B
—
Promotion Service
267.98 M
313.43 M
490.94 M
—
—
Anti-infective Products
720.85 M
—
—
—
—
Cardiovascular Products
505.12 M
—
—
—
—
By country
2017
2018
2019
2020
2021
2022
2023
0.00
2.00 B
4.00 B
6.00 B
8.00 B
China
Currency: HKD
2017
2018
2019
2020
2021
2022
2023
China
5.71 B
5.07 B
6.03 B
7.35 B
7.30 B